Details for Patent: RE50634
Which drugs does patent RE50634 protect, and when does it expire?
Patent RE50634 protects AUGTYRO and is included in one NDA.
This patent has eighty-five patent family members in thirty-six countries.
Summary for Patent: RE50634
| Title: | Diaryl macrocycles as modulators of protein kinases |
| Abstract: | The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation. |
| Inventor(s): | Jingrong Jean Cui, Yishan LI, Evan W. ROGERS, Dayong Zhai |
| Assignee: | Turning Point Therapeutics Inc |
| Application Number: | US18/147,888 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent RE50634
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol | AUGTYRO | repotrectinib | CAPSULE;ORAL | 218213-001 | Nov 15, 2023 | RX | Yes | Yes | RE50634 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Bristol | AUGTYRO | repotrectinib | CAPSULE;ORAL | 218213-002 | Jun 11, 2024 | RX | Yes | Yes | RE50634 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE50634
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3572416 | ⤷ Start Trial | C20250015 | Finland | ⤷ Start Trial |
| European Patent Office | 3572416 | ⤷ Start Trial | 301322 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3572416 | ⤷ Start Trial | CA 2025 00011 | Denmark | ⤷ Start Trial |
| European Patent Office | 3572416 | ⤷ Start Trial | LUC00383 | Luxembourg | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
